Clinical MRI for iron detection in Parkinson's disease

Clin Imaging. 2013 Jul-Aug;37(4):631-6. doi: 10.1016/j.clinimag.2013.02.001. Epub 2013 Mar 20.

Abstract

We studied nonheme iron in Parkinson's disease (PD) using clinically available MRI in 36 patients and 21 healthy volunteers. The subjects underwent thorough clinical investigation, including 3-T MRI. Quantitative R2* was able to reflect symptoms of PD. In addition, the clinically used susceptibility-weighted imaging differentiated between controls and patients, whereas T2-weighted imaging did not. Disease-related changes were present not only in substantia nigra but also in globus pallidus. Such changes are associated with neurodegeneration, reflecting the severity of motor impairment.

Publication types

  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Brain Mapping / methods
  • Caudate Nucleus / chemistry
  • Caudate Nucleus / pathology
  • Corpus Callosum / chemistry
  • Corpus Callosum / pathology
  • Disease Progression
  • Female
  • Globus Pallidus / chemistry*
  • Globus Pallidus / pathology*
  • Humans
  • Iron / analysis*
  • Magnetic Resonance Imaging / methods*
  • Male
  • Middle Aged
  • Parkinson Disease / diagnosis*
  • Substantia Nigra / chemistry*
  • Substantia Nigra / pathology*

Substances

  • Iron